Navigation Links
Silence Therapeutics Signs Collaboration With Mirna Therapeutics to Evaluate Delivery of Novel microRNA Therapeutics

ting multiple cellular pathways and processes. By coordinating the expression of multiple genes, miRNAs are responsible for guiding proper embryonic development, immunity, inflammation, as well as cellular growth and proliferation. Misregulation of miRNAs appears to play a fundamental role in many cancers and replacement of down regulated miRNAs in tumor cells results in a positive therapeutic response

Forward-Looking Statements

This press release includes forward-looking statements that are subject to risks, uncertainties and other factors. These risks and uncertainties could cause actual results to differ materially from those referred to in the forward-looking statements. All forward-looking statements are based on information currently available to Silence Therapeutics and Silence Therapeutics assumes no obligation to update any such forward-looking statements.

For further information, please contact:
Silence Therapeutics
Thomas Christély/Max Herrmann

Singer Capital Markets
Shaun Dobson/Claes Spång
Mirna Therapeutics
Paul Lammers, MD

M:Communications (Europe)
Peter Laing / Emma Thompson
+44-20-7920-2345 / +44-20-7920-2342

Vida Communication (

SOURCE Silence Therapeutics Plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Silence Therapeutics Issued Japanese Patent Covering its Core RNA Interference (RNAi) Technology
2. Silence Therapeutics Lead RNA Interference Therapeutic Prevents Spread of Cancer to Lungs
3. Silence Therapeutics Receives Comprehensive Protection for RNAi Structural Modification Technology in Single European Patent
4. Silence Therapeutics Partner Quark Signs Exclusive Option Agreement With Novartis for Development and Commercialisation of QPI-1002
5. Silence Therapeutics Expands RNAi Structural Modification IP Portfolio With Issuance of New U.S. Patent
6. Silence Therapeutics Issued Novel RNAi Patent Covering High-Value Cancer Target in United States
7. Silence Therapeutics Appoints New Vice President of Research
8. Silence Therapeutics to Present at 12th Annual BIO CEO & Investor Conference
9. National Ovarian Cancer Coalition and PureOlogy to Host First Annual NOCC and PureOlogys Walk to Break the Silence on Ovarian Cancer
10. Amsterdam Molecular Therapeutics Receives Opinion on Re-examination of Glybera® Marketing Authorisation Application
11. Regulus Therapeutics and Collaborators Publish New Pre-Clinical Data on microRNA-33 Demonstrating Key Role in Cholesterol Homeostasis and Fatty Acid Metabolism
Post Your Comments:
(Date:10/8/2015)...  Today the Wyss Institute for Biologically Inspired Engineering ... company Opsonix Inc. The announcement follows a ... Technology Development (OTD) and Opsonix Inc. enabling the ... use. --> --> ... every year in the U.S. — more than prostate ...
(Date:10/7/2015)... , October 8, 2015 ... Medical biotechnology accounts for largest bioinformatics market ... in drug discovery and development process says ... . --> ... the basis of applications, the bioinformatics market ...
(Date:10/7/2015)... , Oct. 7, 2015  ContraVir Pharmaceuticals, Inc. (Nasdaq: ... company focused on the development and commercialization of targeted ... public offering of 5,000,000 shares of its common stock ... the Company,s common stock at a fixed combined price ... stock and warrants will be issued separately.  The warrants ...
(Date:10/7/2015)... (PRWEB) , ... October 07, 2015 , ... ... today announced a webinar titled Smart Nanostructured Coatings to provide a comprehensive overview ... Register for this free webinar at . This webinar will be ...
Breaking Biology Technology:
... May 25, 2010 t2cure GmbH, a biopharmaceutical,company developing and ... product t2c001 has been,certified by the European Medicines Agency (EMA). , ... t2c001 is ... Advanced Therapy Medicinal Products (ATMPs). It is a somatic,cell therapy product derived ...
... ... In the India, CJP is all set to hold 5 Days ... The JatrophaWorld Training Programme 2010-- the Most Authoritative platform shall introduce ... and application technologies, including utilization of Jatropha Crude Oil and Seedcake; ...
... ... ... never before use sustainable farming methods to meet a growing global food demand, and a new ... look at how they do it. , , ,The new website, which can be found ...
Cached Biology Technology:
(Date:9/2/2015)... Biometric technology ... system which uses identical human characteristic such as ... and finger print. Increasing number of terror attacks ... which provides high level of security. Traditional security ... are vulnerable to attacks. Furthermore, Biometric technology uses ...
(Date:8/31/2015)... , August 31, 2015 Growing ... technology in government digitization projects to drive India ... recently published TechSci Research report, " India Biometrics Market Forecast ... is projected to grow at a CAGR of ... is anticipated on account of extensive use of biometric technology ...
(Date:8/28/2015)... August 28, 2015 According to ... Market by Assessment Type (Pen & Paper Based, Hosted, ... Corporate Learning, Academic Research), Vertical and Region - Global ... Training Market to grow from USD 2.4 Billion in ... Compound Annual Growth Rate (CAGR) of 25.6% from 2015 ...
Breaking Biology News(10 mins):
... Wake Forest University School of Medicine suggests that certain inhaled ... during times of high stress ?may worsen diseases such as ... scientific team led by Raymond Penn, Ph.D., and Matthew Loza, ... treatment of asthma, increase the accumulation of type 2 T ...
... Hopkins have shown that transplanting human stem cells into ... disease delays the start of nerve cell damage typical ... stem cells develop into nerve cells that make substantial ... to Lou Gehrig's, also known as amyotrophic lateral sclerosis ...
... with researchers at Rutgers University have solved longstanding ... carrying out instructions contained in our genes. The ... 17 issue of the journal Science reveals important ... transcription and the effects of those gyrations on ...
Cached Biology News:
Request Info...
jub, ajuba homolog (Xenopus laevis)...
AGAROSE PREP, 50G, 1 EA. Category: Genephor Precast Gels....
... Markers, 37 kBq, 1 uCi. Carbon-14 radiolabelled ... the sample on Western blots.The Rainbow-labeled version ... in the gel and on the blot.The ... Rainbow-labeling is 0.37-3.7 MBq/mg (10-100 uCi/mg) or ...
Biology Products: